AT1 and AT2 receptor in the kidney:: Role in health and disease

被引:57
作者
Siragy, HM [1 ]
机构
[1] Univ Virginia, Hlth Syst, Sch Med, Dept Med, Charlottesville, VA 22908 USA
关键词
D O I
10.1016/j.semnephrol.2003.11.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The renin angiotensin system plays an important role in the control of body fluid and electrolyte homeostasis and blood pressure regulation. Angiotensin II is the most effector hormone of this system and functions mainly through stimulation of its subtype receptors, namely, the AT1, and AT2 receptors. Most of the known physiological and pathologic effects of angiotensin II are mediated through stimulation of the AT 1 receptor. The knowledge about the involvement of the AT 2 receptor in physiological and pathologic processes is still evolving. In the kidney, both the AT1 and AT2 receptors contribute to the regulation of renal hemodynamic and tubular functions. Also, these receptors regulate renal cellular growth and matrix formation. However, AT2 receptor possesses functions that counteract the effects of the AT1 receptor. The balance between the AT1 and AT 2 receptors can determine the renal status in health and disease. © 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:93 / 100
页数:8
相关论文
共 100 条
[1]   Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole [J].
Arima, S ;
Endo, Y ;
Yaoita, H ;
Omata, K ;
Ogawa, S ;
Tsunoda, K ;
Abe, M ;
Takeuchi, K ;
Abe, K ;
Ito, S .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11) :2816-2823
[2]   Angiotensin II type 2 receptors in the kidney: evidence for endothelial-cell-mediated renal vasodilatation [J].
Arima, S ;
Ito, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (04) :448-451
[3]  
Arima S., 2001, CLIN EXP NEPHROL, V5, P55
[4]   Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase [J].
Bedecs, K ;
Elbaz, N ;
Sutren, M ;
Masson, M ;
Susini, C ;
Strosberg, AD ;
Nahmias, C .
BIOCHEMICAL JOURNAL, 1997, 325 :449-454
[5]   COUNTERPOINT - MOLECULAR ANALYSIS OF THE ANGIOTENSIN-II RECEPTOR [J].
BERNSTEIN, KE ;
ALEXANDER, RW .
ENDOCRINE REVIEWS, 1992, 13 (02) :381-386
[6]   Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide [J].
Berry, C ;
Touyz, R ;
Dominiczak, AF ;
Webb, RC ;
Johns, DG .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (06) :H2337-H2365
[7]   Investigation into the sources of superoxide in human blood vessels - Angiotensin II increases superoxide production in human internal mammary arteries [J].
Berry, C ;
Hamilton, CA ;
Brosnan, J ;
Magill, FG ;
Berg, GA ;
McMurray, JJV ;
Dominiczak, AF .
CIRCULATION, 2000, 101 (18) :2206-2212
[8]   Angiotensin II activates collagen type I gene in the renal vasculature of transgenic mice during inhibition of nitric oxide synthesis - Evidence for an endothelin-mediated mechanism [J].
Boffa, JJ ;
Tharaux, PL ;
Placier, S ;
Ardaillou, R ;
Dussaule, JC ;
Chatziantoniou, C .
CIRCULATION, 1999, 100 (18) :1901-1908
[9]   Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT(1) receptors [J].
Brannstrom, K ;
Morsing, P ;
Arendshorst, WJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1996, 270 (05) :F749-F755
[10]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869